|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-5-13
|
|
pubmed:abstractText |
In the involved epidermis of patients with atopic dermatitis, changes in the metabolism of eicosanoids with increased quantities of the arachidonic acid (AA)-derived lipoxygenase products have been observed. Free eicosapentaenoic acid (EPA), a fish oil-derived alternative (n-3) fatty acid, may compete with AA, resulting in an anti-inflammatory effect.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0148-6071
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
151-8
|
|
pubmed:dateRevised |
2007-2-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12005454-Adolescent,
pubmed-meshheading:12005454-Adult,
pubmed-meshheading:12005454-Arachidonic Acids,
pubmed-meshheading:12005454-Dermatitis, Atopic,
pubmed-meshheading:12005454-Double-Blind Method,
pubmed-meshheading:12005454-Eicosapentaenoic Acid,
pubmed-meshheading:12005454-Fat Emulsions, Intravenous,
pubmed-meshheading:12005454-Fatty Acids, Omega-3,
pubmed-meshheading:12005454-Fatty Acids, Omega-6,
pubmed-meshheading:12005454-Fatty Acids, Unsaturated,
pubmed-meshheading:12005454-Female,
pubmed-meshheading:12005454-Humans,
pubmed-meshheading:12005454-Infusions, Parenteral,
pubmed-meshheading:12005454-Kinetics,
pubmed-meshheading:12005454-Male,
pubmed-meshheading:12005454-Severity of Illness Index
|
|
pubmed:articleTitle |
A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis.
|
|
pubmed:affiliation |
Department of Dermatology, Center for Dermatology and Andrology, Justus-Liebig-University, Giessen, Germany. Peter.Mayser@derma.med.uni-giessen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
